Predictions
Wheaton Precious Metals Corp.
Start price
Target price
Perf. (%)
€36.08
13.12.21
13.12.21
-
13.12.22
13.12.22
4.19%
25.12.21
25.12.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Canopy Growth Corp
Start price
Target price
Perf. (%)
€8.47
13.12.21
13.12.21
-
13.12.22
13.12.22
-67.06%
14.12.22
14.12.22
Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
Cronos Group Inc.
Start price
Target price
Perf. (%)
€3.79
13.12.21
13.12.21
-
13.12.22
13.12.22
-19.99%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Algernon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€0.83
12.12.21
12.12.21
-
12.12.22
12.12.22
-12.65%
30.12.21
30.12.21
Probably not worthwhile Investment
Lithium Americas Corp.
Start price
Target price
Perf. (%)
€31.51
09.12.21
09.12.21
€34.00
09.12.22
09.12.22
-27.94%
13.10.22
13.10.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Very low/no dividend yield expected
Wheaton Precious Metals Corp.
Start price
Target price
Perf. (%)
€34.91
06.12.21
06.12.21
€40.00
06.12.22
06.12.22
6.12%
06.12.22
06.12.22
Could be worthwhile Investment >10% per year
Barrick Gold Corp
Start price
Target price
Perf. (%)
€16.10
06.12.21
06.12.21
€20.00
06.12.22
06.12.22
-2.34%
06.12.22
06.12.22
Could be worthwhile Investment >10% per year
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€5.22
05.12.21
05.12.21
€2.70
05.12.22
05.12.22
-44.67%
16.03.22
16.03.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Ballard Power Systems Inc.
Start price
Target price
Perf. (%)
€12.14
05.12.21
05.12.21
€18.00
05.12.22
05.12.22
-52.54%
06.12.22
06.12.22
Could be worthwhile Investment >10% per year
BELLUS Health Inc.
Start price
Target price
Perf. (%)
€4.62
02.12.21
02.12.21
-
02.12.22
02.12.22
45.82%
12.12.21
12.12.21
Risky Investment
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€4.85
01.12.21
01.12.21
-
01.12.22
01.12.22
-53.67%
02.12.22
02.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.96
01.12.21
01.12.21
€6.00
01.12.22
01.12.22
-2.70%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Innovative
Good culture
Below average Management
Ballard Power Systems Inc.
Start price
Target price
Perf. (%)
€13.43
30.11.21
30.11.21
-
30.11.22
30.11.22
-52.14%
23.06.22
23.06.22
Risky Investment
Increased challenges to pay loans and raise capital
Higher risks for its business
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€39.25
30.11.21
30.11.21
-
30.11.22
30.11.22
-17.83%
12.12.21
12.12.21
Probably not worthwhile Investment
Fennec Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.22
29.11.21
29.11.21
-
29.11.22
29.11.22
-16.11%
12.12.21
12.12.21
Could be worthwhile Investment >10% per year
Yamana Gold Inc.
Start price
Target price
Perf. (%)
€3.62
29.11.21
29.11.21
-
29.11.22
29.11.22
-4.69%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Wheaton Precious Metals Corp.
Start price
Target price
Perf. (%)
€37.69
29.11.21
29.11.21
-
29.11.22
29.11.22
-4.27%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Pan American Silver Corp.
Start price
Target price
Perf. (%)
€22.81
29.11.21
29.11.21
-
29.11.22
29.11.22
-7.80%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Barrick Gold Corp
Start price
Target price
Perf. (%)
€17.30
29.11.21
29.11.21
-
29.11.22
29.11.22
-6.94%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Known brand
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.00
28.11.21
28.11.21
-
28.11.22
28.11.22
7.65%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
American Lithium Corp
Start price
Target price
Perf. (%)
€3.71
27.11.21
27.11.21
€2.00
27.11.22
27.11.22
-40.27%
16.03.22
16.03.22
EBIT growth >5% per year expected
Fair valuation
Very low/no dividend yield expected
negative Cash Flow expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.50
22.11.21
22.11.21
-
22.11.22
22.11.22
-2.83%
28.11.21
28.11.21
Risky Investment
Apex Resources Inc.
Start price
Target price
Perf. (%)
€0.076
21.11.21
21.11.21
€0.12
-
04.03.23
04.03.23
Could be worthwhile Investment >10% per year